National Human Genome Research Institute; Notice of Closed Meeting, 61958 [2020-21674]
Download as PDF
<![CDATA[
61958
Federal Register / Vol. 85, No. 191 / Thursday, October 1, 2020 / Notices
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: October 27, 2020.
Closed: 10:00 a.m. to 12:00 p.m.
Agenda: To Review and Evaluate Grant
Applications and/or Proposals.
Place: NIH, Bethesda, MD (Virtual
Meeting).
Open: 12:30 p.m. to 5:00 p.m.
Agenda: To Discuss Program Policies and
Issues.
Place: NIH, Bethesda, MD (Virtual
Meeting).
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast. https://www.nhlbi.nih.gov/about/
advisory-and-peer-review-committees/
advisory-council. Please note, the link to the
videocast meeting will be posted within a
week of the meeting date.
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 206–Q, Bethesda, MD
20892, 301–827–5517, moenl@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. Any
member of the public may submit written
comments no later than 15 days after the
meeting.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 25, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21673 Filed 9–30–20; 8:45 am]
22:13 Sep 30, 2020
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Advancing Genomic Medicine
Research.
Date: December 1, 2020.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 300, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Barbara J. Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 300, Bethesda, MD
20892–9306, 301–402–0838,
barbara.thomas@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 25, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–21674 Filed 9–30–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. to achieve
SUMMARY:
BILLING CODE 4140–01–P
VerDate Sep<11>2014
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jkt 253001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
expeditious commercialization of
results of federally-funded research and
development.
FOR FURTHER INFORMATION CONTACT:
Licensing information may be obtained
by emailing Brian W. Bailey, Ph.D.,
bbailey@mail.nih.gov, the indicated
licensing contact at the National Heart,
Lung, and Blood, Office of Technology
Transfer and Development Office of
Technology Transfer, 31 Center Drive,
Room 4A29, MSC2479, Bethesda, MD
20892–2479; telephone: 301–402–5579.
A signed Confidential Disclosure
Agreement may be required to receive
any unpublished information.
SUPPLEMENTARY INFORMATION:
Technology description follows.
Methods To Produce Very Long-Chain
Fatty Acids (VLCFA)
Available for licensing and
commercial development are patent
rights covering methods for
synthetically producing highly pure,
polyunsaturated very long-chain fatty
acids (C20–C40) that are highly scalable,
do not require toxic mercury, and are
applicable to the synthesis of highly
deuterated (≤90%), partially deuterated,
and non-deuterated lipids. VLCFAs,
while present in very small
concentrations in living organisms,
nonetheless play vital roles in certain
biological processes. The present
invention addresses an unmet need for
VLCFAs for experimental and
therapeutic uses that is currently
inadequately met through labor
intensive and time consuming
extractions from natural sources or
technically difficult overexpression in
cell cultures, which give very small
yields. This invention also includes a
method for treating and preventing
macular degeneration using VLCFAs.
This technology is available for
licensing for commercial development
in accordance with 35 U.S.C. 209 and 37
CFR part 404.
Potential Commercial Applications:
• Synthesis of very-long chain fatty
acids for in vitro and in vivo research
purposes
• Synthesis of very-long chain fatty
acids for therapeutic purposes
• Treatment and prevention of macular
degeneration, inflammatory disorders
and other disorders and conditions
associated with very long-chain fatty
acid deficiencies
Development Stage:
• Preclinical
• Mouse data
Inventors: Rolf Swenson (NHLBI),
Zhen-Dan Shi (NHLBI), Zhi-Hong Yang
(NHLBI) and Alan Remaley (NHLBI).
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 85, Number 191 (Thursday, October 1, 2020)]
[Notices]
[Page 61958]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21674]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; Advancing Genomic Medicine Research.
Date: December 1, 2020.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 300, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Barbara J. Thomas, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B Rockledge Drive,
Suite 300, Bethesda, MD 20892-9306, 301-402-0838,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: September 25, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-21674 Filed 9-30-20; 8:45 am]
BILLING CODE 4140-01-P
